ROSSI, LUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 14.687
EU - Europa 14.195
AS - Asia 5.750
SA - Sud America 414
AF - Africa 70
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 17
Totale 35.170
Nazione #
US - Stati Uniti d'America 14.535
NL - Olanda 5.614
GB - Regno Unito 3.149
CN - Cina 2.860
SG - Singapore 1.596
UA - Ucraina 1.269
IT - Italia 1.001
SE - Svezia 740
RU - Federazione Russa 585
FI - Finlandia 540
DE - Germania 518
TR - Turchia 472
BR - Brasile 324
IE - Irlanda 281
FR - Francia 263
VN - Vietnam 203
JP - Giappone 158
IN - India 108
CA - Canada 94
KR - Corea 60
HK - Hong Kong 52
PL - Polonia 50
MX - Messico 46
ES - Italia 40
PK - Pakistan 39
AU - Australia 34
BE - Belgio 34
BD - Bangladesh 33
AR - Argentina 30
ZA - Sudafrica 28
IQ - Iraq 22
IR - Iran 18
RO - Romania 18
SA - Arabia Saudita 17
AT - Austria 16
EC - Ecuador 15
ID - Indonesia 15
AE - Emirati Arabi Uniti 14
EU - Europa 14
LT - Lituania 13
VE - Venezuela 13
CL - Cile 12
TG - Togo 12
CO - Colombia 11
MA - Marocco 11
IL - Israele 10
PT - Portogallo 10
CH - Svizzera 8
KZ - Kazakistan 8
UZ - Uzbekistan 8
JO - Giordania 7
PH - Filippine 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 5
LV - Lettonia 5
NO - Norvegia 5
PA - Panama 5
TH - Thailandia 5
TN - Tunisia 5
AM - Armenia 4
CR - Costa Rica 4
GE - Georgia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
EE - Estonia 3
EG - Egitto 3
KE - Kenya 3
KH - Cambogia 3
LB - Libano 3
LK - Sri Lanka 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PE - Perù 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PY - Paraguay 2
RS - Serbia 2
SI - Slovenia 2
SM - San Marino 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
JM - Giamaica 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
Totale 35.163
Città #
Amsterdam 5.595
Southend 2.825
Fairfield 1.692
Woodbridge 1.548
Ashburn 1.350
Houston 1.091
Jacksonville 1.010
Ann Arbor 892
Singapore 815
Chandler 738
Cambridge 653
Seattle 647
San Jose 611
Wilmington 580
Nanjing 542
Dallas 415
Beijing 390
Izmir 348
Dublin 279
Boardman 267
Urbino 243
Helsinki 239
Nanchang 229
New York 189
Los Angeles 173
San Mateo 167
Lauterbourg 160
Princeton 149
Shenyang 125
Hebei 120
Jiaxing 102
Düsseldorf 99
Munich 97
Tianjin 97
Changsha 84
Ho Chi Minh City 70
Istanbul 70
Buffalo 69
Council Bluffs 67
Kunming 62
San Diego 61
Mülheim 57
Bremen 55
Moscow 52
San Francisco 52
Jinan 51
Santa Clara 51
Seongnam 50
São Paulo 50
Tokyo 47
Shanghai 46
Guangzhou 45
London 45
Orem 44
Hangzhou 42
Hong Kong 42
Zhengzhou 42
Hanoi 41
Toronto 39
Frankfurt am Main 37
Poplar 35
Warsaw 33
Brussels 32
Rome 31
Velikiy Novgorod 31
Montreal 30
Brooklyn 29
Turku 29
Ningbo 27
Atlanta 26
Chennai 26
Chicago 26
Stockholm 24
Changchun 23
Denver 23
Ancona 22
Des Moines 22
Taizhou 21
Bologna 20
Johannesburg 19
Auburn Hills 17
Fano 16
Manchester 16
Paris 16
Portsmouth 16
Redwood City 16
Mexico City 15
Rawalpindi 15
Ankara 14
Augusta 14
Leawood 14
Querétaro 14
Riyadh 14
Shenzhen 14
Nuremberg 13
Alexandria 12
Boston 12
Haiphong 12
Kraków 12
Lanzhou 12
Totale 26.661
Nome #
Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs 2.019
Efficient and highly reproducible production of red blood cell-derived extracellular vesicle mimetics for the loading and delivery of RNA molecules 2.006
Red blood cells could protect miRNAs from degradation or loss thanks to Argonaute 2 binding 1.922
Reengineering red blood cells for cellular therapeutics and diagnostics 392
A new therapy prevents intellectual disability in mouse with phenylketonuria 325
Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment 323
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 293
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 282
2',3'-Dideoxycytidine induced drug resistance in human cells 274
A NONLINEAR THREE-COMPARTMENT MODEL FOR THE ADMINISTRATION OF 2’, 3’- DIDEOXYCYTIDINE BY USING RED BLOOD CELLS AS BIOREACTORS 273
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines. 272
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 270
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs 266
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 265
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 262
A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus 261
Improved cellular uptake of functionalized single-walled carbon nanotubes 260
In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia 256
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications 253
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells 251
Erythrocyte-based drug delivery 250
ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T 249
Drug delivery through phagocytosis of red blood cells 247
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir 246
Label-free quantification of Tacrolimus in biological samples by atomic force microscopy 244
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38 244
Acetaldehyde, ethanol and acetone concentrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes 242
Drug delivery by red blood cells 240
Erythrocytes as a controlled drug delivery system: clinical evidences 238
Ultrastructural analysis of pancreatic acinar cells from mice fed on genetically modified soybean 238
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 238
Drug delivery systems 235
2',3'- Dideoxycytidine permeation of the human erythrocyte membrane. 233
Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde 231
Approaches to erythrocyte-mediated drug delivery 231
Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice 231
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 230
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 229
Human red blood cells as bioreactors for the release of 2', 3'-dideoxycytidine, an inhibitor of HIV infectivity. 228
Acyclovir prodrug and its use in pharmaceutical compositions 227
Targeting antiviral nucleotide analogues to macrophages 227
Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment 225
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 224
Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes 222
Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues 219
Acetaldehyde oxidation by aldehyde dehydrogenase-loaded erythrocytes. 217
Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages 214
Inhibition of murine AIDS by reduced glutathione. 212
Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells 212
Redox homeostasis as a target for new antimycobacterial agents 208
Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells 205
Use of nonvolatile buffers in liquid chromatography/mass spectrometry: advantages of capillary-scale particle beam interfacing 204
Targeting nucleotide dimers containing antiviral nucleosides 204
Red Blood Cell Membrane Processing for Biomedical Applications 204
An ex-vivo erythrocyte model for investigating oxidative metabolism 202
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. 195
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity 194
Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study 194
Erythrocyte-mediated delivery of recombinant enzymes 193
A new homodimer of acyclovir as a prodrug with increased solubility and antiviral activity 193
Macrophage protection by nucleoside and nucleotide analogue administration 192
Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes 192
Acetaldehyde, ethanol and acetone concetrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes. 191
Membrane-bound immunoglobulins increase during red blood cell aging. 191
Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging 191
Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus 189
Fine distribution of CLOCK protein in hepatocytes of hibernating dormice. 188
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes 187
REVERSED-PHASE LIQUID CHROMATOGRAPHIC DETERMINATION OF 2’, 3’-DIDEOXYCYTIDINE IN HUMAN BLOOD SAMPLES 187
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 187
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 186
Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies 186
ALCUNE PROPRIETÀ DI GLOBULI ROSSI UMANI SOTTOPOSTI A DIALISI IPOTONICA E RISIGILLAMENTO DA UTILIZZARE COME VEICOLI O BIOREATTORI. 185
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 184
Red blood cell phagocytosis following hexokinase inactivation. 184
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. 180
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 178
FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate. 177
Azidothymidine homodinucleotide-loaded erythrocytes and bioreactors for slow delivery of the antiretroviral drug azidothymidine 176
Synthesis and biological application of a new heterodinucleotide with both anti-HSV and anti-HIV activity 176
Effect of phenylhydrazine on red blood cell metabolism. 176
Modulated red blood cell survival by membrane protein clustering 176
Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir 175
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 175
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5'-triphosphate 174
Effect of age on some properties of mice erythrocytes 173
In vitro and in vivo methanol degradation by alcohol oxidase-loaded erythrocytes 173
Preparation of glutathione derivatives as antiviral agents 173
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 172
Improved metabolic properties of hexokinase-overloaded human erythrocytes 171
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 171
Preclinical developments of enzyme-loaded red blood cells 171
Macrophage uptake of SWNT-COOC18H37 derivatives coated by phosphatidylethanolamine or phosphatidylserine 170
Synthesis, caracterization and erythrocyte encapsulation of an azidothymidine homodinucleotide 170
Erythrocytes-mediated delivery of Dexamethasone in steroid-dependent IBD patients – A pilot uncontrolled study 167
Improved stability of 2,3-bisphosphoglycerate during storage of hexokinase-overloaded erythrocytes 166
Macrophage protection by nucleoside and nucleotide analogue administration 166
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 166
Erythrocytes as pharmacological carriers for corticosteroids and other drugs in patients with inflammatory bowel diseases 165
Red blood cells as an antigen-delivery system. 164
Totale 26.765
Categoria #
all - tutte 106.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021781 0 0 0 0 0 0 0 0 0 242 389 150
2021/20221.665 140 130 171 219 69 59 66 95 124 119 32 441
2022/20232.447 300 107 40 242 246 527 7 174 433 121 160 90
2023/2024697 77 72 47 89 56 143 21 26 8 87 7 64
2024/20252.731 137 132 593 184 81 188 278 154 284 197 255 248
2025/202611.391 586 598 678 1.053 635 391 881 217 5.958 394 0 0
Totale 35.482